Skip to main content

Promising UCF technology is illuminating new ways to examine molecules with precision, an advancement that can help enhance drug development and new therapies.

The new technology, a plasmonic platform that significantly improves the detection of the chirality of molecules, was developed by UCF NanoScience Technology Center Professor Debashis Chanda. The work is detailed in a new study published in Science Advances.

Chiral molecules are like pairs of molecules that are similar in structure but are twisted differently (left or right), similar to how a person’s left and right hands are mirror images of each other.

Understanding the nature of chiral molecules is central to biological and pharmaceutical research because the mirror image pairs — known as enantiomers — can each have different effects in the body or in chemical reactions.

Nearly 56% of all modern drugs and medicine are chiral in nature and about 90% of those are a mixture containing equal amounts of two enantiomers of a chiral compound.

Read article from UCF Today.
By Eddy Duryea | March 13, 2024

The UCF-developed plasmonic technology, shown here, significantly improves the detection of the chirality of molecules, meeting a crucial demand in the field of medical and pharmaceutical research.